His primary scientific interests are in Immunology, Intensive care medicine, Blood transfusion, Randomized controlled trial and Internal medicine. His Immunology study frequently draws connections between adjacent fields such as Transplantation. Morris A. Blajchman combines subjects such as Transfusion-related acute lung injury, Lung injury, Allogeneic transfusion and Consensus conference with his study of Intensive care medicine.
The Blood transfusion study combines topics in areas such as Blood product and MEDLINE. His Randomized controlled trial study integrates concerns from other disciplines, such as Observational study, Clinical trial, Anemia and Pediatrics. His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology and Mutation.
Morris A. Blajchman focuses on Immunology, Internal medicine, Biochemistry, Platelet and Antithrombin. Morris A. Blajchman regularly links together related areas like Transplantation in his Immunology studies. Morris A. Blajchman combines subjects such as Gastroenterology, Endocrinology and Surgery with his study of Internal medicine.
His Biochemistry research is multidisciplinary, incorporating elements of Molecular biology, Coagulation, Tissue factor and Thrombin. His study in Platelet is interdisciplinary in nature, drawing from both Hemostasis, Pharmacology and Sepsis. The Blood transfusion study combines topics in areas such as Pediatrics and Intensive care medicine.
Morris A. Blajchman mainly investigates Immunology, Intensive care medicine, Randomized controlled trial, Blood transfusion and Transfusion medicine. His work in Immunology is not limited to one particular discipline; it also encompasses Transplantation. In his study, which falls under the umbrella issue of Intensive care medicine, Blood product and Organ dysfunction is strongly linked to Adverse effect.
His research integrates issues of Anesthesia, Observational study, Anemia and Pediatrics in his study of Randomized controlled trial. He interconnects Spleen and Monoclonal antibody in the investigation of issues within Blood transfusion. His Sepsis research is within the category of Internal medicine.
The scientist’s investigation covers issues in Intensive care medicine, Randomized controlled trial, Immunology, Blood transfusion and Sepsis. His Intensive care medicine research is multidisciplinary, incorporating perspectives in Risk of mortality and Epidemiology. Morris A. Blajchman has researched Randomized controlled trial in several fields, including Observational study, Clinical trial, Relative risk, Anemia and Pediatrics.
His Immunology study combines topics from a wide range of disciplines, such as Blood-Borne Pathogens and Transplantation. His Sepsis study is concerned with the field of Internal medicine as a whole. His specific area of interest is Internal medicine, where he studies Hematology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group.
Paul C. Hébert;George Wells;Morris A. Blajchman;John Marshall.
The New England Journal of Medicine (1999)
A Comparison of Aprotinin and Lysine Analogues in High-Risk Cardiac Surgery
Dean A. Fergusson;Paul C. Hébert;C. David Mazer;Stephen Fremes.
The New England Journal of Medicine (2008)
Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases
Paul C. Hébert;Elizabeth Yetisir;Claudio Martin;Morris A. Blajchman.
Critical Care Medicine (2001)
Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention
Eleftherios C. Vamvakas;Morris A. Blajchman;Morris A. Blajchman.
Blood (2009)
Transfusion-related immunomodulation (TRIM): An update
Eleftherios C. Vamvakas;Morris A. Blajchman.
Blood Reviews (2007)
The premature infants in need of transfusion (pint) study: A randomized, controlled trial of a restrictive (LOW) versus liberal (HIGH) transfusion threshold for extremely low birth weight infants
Haresh Kirpalani;Robin K. Whyte;Chad Andersen;Elizabeth V. Asztalos.
The Journal of Pediatrics (2006)
Age of Transfused Blood in Critically Ill Adults
Jacques Lacroix;Paul C. Hébert;Dean A. Fergusson;Alan Tinmouth.
The New England Journal of Medicine (2015)
Biologic effects of leukocytes present in transfused cellular blood products
JO Bordin;NM Heddle;MA Blajchman.
Blood (1994)
Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction?
Eleftherios C. Vamvakas;Morris A. Blajchman.
Blood (2001)
Effects of Red-Cell Storage Duration on Patients Undergoing Cardiac Surgery
Marie E. Steiner;Paul M. Ness;Susan F. Assmann;Darrell J. Triulzi.
The New England Journal of Medicine (2015)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
McMaster University
University of Montreal
Ottawa Hospital
McMaster University
University of Alberta
McMaster University
University of Ottawa
University of Toronto
McMaster University
McMaster University
University of Southern California
National and Kapodistrian University of Athens
NTT (Japan)
National Taiwan University
Beijing University of Chemical Technology
University of Connecticut
Soochow University
University of Regina
Oxford Brookes University
Southern Methodist University
National Institutes of Health
Brigham and Women's Hospital
Medical College of Wisconsin
University of Tübingen
Rice University
National Institute of Astrophysics, Optics and Electronics